Outset Medical

Outset Medical FCF Growth

The Year-over-Year Free Cash Flow Growth of Outset Medical (OM) as of Oct 22, 2026 is 59.80 %. In the previous year, Year-over-Year Free Cash Flow Growth was 13.05 % — a change of 358.08% (higher).

FCF Growth

59.80 %

YoY

358.08%

Last updated:

Year-over-Year Free Cash Flow Growth of Outset Medical is 2025 59.80 % . Year-over-Year Free Cash Flow Growth of Outset Medical was 2024 13.05 % . It decreases by 358.08% higher compared to the previous year.

The Outset Medical FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2019
-52.64 USD
Jan 1, 2020
-46.94 USD
Jan 1, 2021
-23.35 USD
Jan 1, 2022
-15.51 USD
Jan 1, 2023
12.49 USD
Jan 1, 2024
13.05 USD
Jan 1, 2025
59.80 USD
The Outset Medical FCF Growth history
YEARFCF GrowthYoY
59.80 %+358.08%
13.05 %+4.51%
12.49 %-180.54%
-15.51 %-33.59%
-23.35 %-50.25%
-46.94 %-10.84%
-52.64 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Outset Medical Stock analysis

What does Outset Medical do? Outset Medical Inc, based in San Jose, California, is a health care technology company specializing in dialysis solutions. The company offers Tablo, a versatile dialysis machine providing acute and chronic treatment through customizable dialysate, touchscreen guidance, and integrated water purification. Tablo enables on-demand dialysis production and functions as a mobile clinic, supporting healthcare providers in hospital and home settings. Founded in 2014, the company listed on the stock market in 2020 and employs 310 full-time staff. Outset Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Outset Medical stock

Year-over-Year Free Cash Flow Growth of Outset Medical is 59.80 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Outset Medical since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Outset Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Outset Medical

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Outset Medical